Demonstrating expertise in complex financings, growth investments, and joint acquisitions, Gibson, Dunn & Crutcher draws extensively upon its cross-border capabilities, especially with the US and Europe. The team is spearheaded by Wim De Vlieger and Federico Fruhbeck, with the former being an expert in buyout transactions and exits, while the latter is highly knowledgeable in multi-jurisdictional M&A transactions. Isabel Berger and Till Lefranc are both also highlighted as key.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘I strongly recommend working with Till Lefranc and his team. Very responsive, excellent lawyer, always a pleasure working with him. He excels at tech deals and has a strong track record on French transactions too.’

  • ‘Jakob Egle and his team are really outstanding. Jakob is the lawyer you need when you must close a deal.’

  • ‘Jakob Egle is always available, super smart, super repsonsive.’

  • ‘The team is very strong, with excellent project management capabilities and a solid commercial understanding.’

  • ‘The team has great expertise, is extremely proactive and has a deep knowledge of the industry and the market practices.’

  • ‘Till Lefranc has great experience with growth equity and minority deals.’

Key clients

  • KKR
  • RedBird Capital Partners
  • Novator Ventures
  • Blue Earth Capital AG
  • Otro Capital
  • Dawn Biopharma
  • Frontier Biosolutions
  • Biosynth Carbosynth
  • Argenta
  • Clinisupplies
  • Ottawa Avenue Private Capital
  • Oaktree Capital Management

Practice head

Wim De Vlieger; Federico Fruhbeck

Other key lawyers

Isabel Berger; Alice Brogi; Robert Dixon; Claibourne Harrison; Patrick Hennessy; Jeremy Kenley; Till Lefranc; Amar Madhani; Mark Sperotto; Will Summers; Jakob Egle